Marc Van de Casteele

716 total citations
24 papers, 426 citations indexed

About

Marc Van de Casteele is a scholar working on Hepatology, Epidemiology and Physiology. According to data from OpenAlex, Marc Van de Casteele has authored 24 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 10 papers in Epidemiology and 7 papers in Physiology. Recurrent topics in Marc Van de Casteele's work include Liver Disease and Transplantation (15 papers), Liver Disease Diagnosis and Treatment (9 papers) and Nitric Oxide and Endothelin Effects (6 papers). Marc Van de Casteele is often cited by papers focused on Liver Disease and Transplantation (15 papers), Liver Disease Diagnosis and Treatment (9 papers) and Nitric Oxide and Endothelin Effects (6 papers). Marc Van de Casteele collaborates with scholars based in Belgium, Netherlands and Italy. Marc Van de Casteele's co-authors include Johan Fevery, Frederik Nevens, Jürg Reichen, Jos van Pelt, Tania Roskams, Hans Sägesser, Marcel Zeegers, Heinz Zimmermann, Tamara Severi and Ingrid Vander Elst and has published in prestigious journals such as Hepatology, Gut and Journal of Hepatology.

In The Last Decade

Marc Van de Casteele

24 papers receiving 409 citations

Peers

Marc Van de Casteele
Marc Van de Casteele
Citations per year, relative to Marc Van de Casteele Marc Van de Casteele (= 1×) peers Yuzuru Sato

Countries citing papers authored by Marc Van de Casteele

Since Specialization
Citations

This map shows the geographic impact of Marc Van de Casteele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Van de Casteele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Van de Casteele more than expected).

Fields of papers citing papers by Marc Van de Casteele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Van de Casteele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Van de Casteele. The network helps show where Marc Van de Casteele may publish in the future.

Co-authorship network of co-authors of Marc Van de Casteele

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Van de Casteele. A scholar is included among the top collaborators of Marc Van de Casteele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Van de Casteele. Marc Van de Casteele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vreman, Rick A., et al.. (2023). The Beneluxa Initiative domain task force health technology assessment: a comparison of member countries’ past health technology assessments. International Journal of Technology Assessment in Health Care. 39(1). e44–e44. 2 indexed citations
2.
Casteele, Marc Van de, et al.. (2023). Patients, payers and developers of Orphan Medicinal Products: lessons learned from 10 years’ multi-stakeholder dialogue on improving access in Europe via MoCA. Orphanet Journal of Rare Diseases. 18(1). 144–144. 8 indexed citations
3.
Eichler, Hans‐Georg, Róisín Adams, Peter Arlett, et al.. (2021). Exploring the opportunities for alignment of regulatory postauthorization requirements and data required for performance-based managed entry agreements. International Journal of Technology Assessment in Health Care. 37(1). e83–e83. 15 indexed citations
4.
Pasternack, Iris, Jenni M. Vuola, Marc Van de Casteele, et al.. (2014). PILOTING INTERNATIONAL PRODUCTION OF RAPID RELATIVE EFFECTIVENESS ASSESSMENTS OF PHARMACEUTICALS. International Journal of Technology Assessment in Health Care. 30(5). 521–529. 3 indexed citations
5.
Pasternack, Iris, et al.. (2014). STANDARDIZED REPORTING FOR RAPID RELATIVE EFFECTIVENESS ASSESSMENTS OF PHARMACEUTICALS. International Journal of Technology Assessment in Health Care. 30(5). 488–496. 11 indexed citations
6.
Declercq, Jeroen, Anujith Kumar, Conny Gysemans, et al.. (2011). Pdx1- and Ngn3-Cre-Mediated PLAG1 Expression in the Pancreas Leads to Endocrine Hormone Imbalances That Affect Glucose Metabolism. Cell Transplantation. 20(8). 1285–1297. 3 indexed citations
7.
Laleman, Wim, Marc Van de Casteele, Marcel Zeegers, et al.. (2005). A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis†‡. Hepatology. 42(6). 1382–1390. 65 indexed citations
8.
Casteele, Marc Van de, et al.. (2004). Halofuginone can worsen liver fibrosis in bile duct obstructed rats. Liver International. 24(5). 502–509. 9 indexed citations
9.
Casteele, Marc Van de, et al.. (2002). Blood antioxidant levels in patients with alcoholic liver disease correlate with the degree of liver impairment and are not specific to alcoholic liver injury itself. Alimentary Pharmacology & Therapeutics. 16(5). 985–992. 20 indexed citations
11.
Casteele, Marc Van de, Hans Sägesser, Heinz Zimmermann, & Jürg Reichen. (2001). Characterisation of portal hypertension models by microspheres in anaesthetised rats: a comparison of liver flow. Pharmacology & Therapeutics. 90(1). 35–43. 27 indexed citations
12.
Roskams, Tania, Marc Van de Casteele, Frederik Nevens, Valeer Desmet, & Johan Fevery. (2000). Enhanced co-experession of eNOS and iNOS in dilated sinusoids in advanced primary biliary cirrhosis, suggests a role for these NOS isoforms in intrahepatic portohepatic blood shunting. Hepatology. 32(4). 2 indexed citations
13.
Casteele, Marc Van de, et al.. (1999). Intraportal administration of glyceryl trinitrate or nitroprusside exerts more systemic than intrahepatic effects in anaesthetised cirrhotic rats. Journal of Hepatology. 31(2). 300–305. 14 indexed citations
14.
Diamantis, Ioannis, et al.. (1998). Detection of endothelin-1 and its receptors in rat liver endothelial cells by in situ reverse transcriptase-polymerase chain reaction. Journal of Hepatology. 28(1). 157–160. 9 indexed citations
15.
Gayan‐Ramirez, Ghislaine, Marc Van de Casteele, Johan Fevery, et al.. (1998). Biliary cirrhosis induces type IIx/b fiber atrophy in rat diaphragm and skeletal muscle, and decreases IGF-I mRNA in the liver but not in muscle. Journal of Hepatology. 29(2). 241–249. 26 indexed citations
16.
Casteele, Marc Van de, et al.. (1996). Effect of terlipressin on portal pressure and on renal function in cirrhotic rats. Hepatology. 23. 1 indexed citations
17.
Casteele, Marc Van de, Stefan Janssens, Tania Roskams, et al.. (1996). In vivo gene transfer of NO synthase reduces portal pressure in experimental cirrhosis in rats. Hepatology. 24(4). 747–747. 3 indexed citations
18.
Roskams, Tania, Marc Van de Casteele, Frederik Nevens, Johan Fevery, & Valeer Desmet. (1996). Different expression of NO synthase in human cirrhotic liver specimens may be related to different mechanisms of portal hypertension. Hepatology. 24. 2 indexed citations
19.
Casteele, Marc Van de, et al.. (1996). Low doses of spironolactone reduce portal vein pressure without affecting plasma volume in the rat. Journal of Hepatology. 25. 1 indexed citations
20.
Casteele, Marc Van de, G. Verhoef, H Demuynck, Pierre Zachée, & M. A. Boogaerts. (1994). Hypercalcemia, monoclonal protein, and osteolytic bone lesions in chronic lymphocytic leukemia. Annals of Hematology. 69(2). 79–80. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026